Home  |  Contact
Due to maintenance work, this service will be unavailable Mon Feb 13 between 07:00 and 09:30 - CET. Apologies for the inconvenience.

UniProtKB/Swiss-Prot P32245: Variant p.Gly181Asp

Melanocortin receptor 4
Gene: MC4R
Variant information

Variant position:  181
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Aspartate (D) at position 181 (G181D, p.Gly181Asp).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to medium size and acidic (D)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In obesity; does not bind alpha-MSH.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  181
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  332
The length of the canonical sequence.

Location on the sequence:   MTVKRVGIIISCIWAACTVS  G ILFIIYSDSSAVIICLITMF
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         MTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMF

Mouse                         MTVRRVGIIISCIWAACTVSGVLFIIYSDSSAVIICLISMF

Rat                           MTVRRVGIIISCIWAACTVSGVLFIIYSDSSAVIICLITMF

Pig                           MTVKRVGIIISCIWAVCTVSGVLFIIYSDSSAVIICLITVF

Bovine                        MTVKRVAITISAIWAACTVSGVLFIIYSDSSAVIICLITVF

Zebrafish                     MTQRRAGTIITCIWTFCTVSGVLFIVYSESTTVLICLISMF

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 332 Melanocortin receptor 4
Transmembrane 166 – 186 Helical; Name=4
Helix 163 – 186


Literature citations

Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity.
Larsen L.H.; Echwald S.M.; Soerensen T.I.A.; Andersen T.; Wulff B.S.; Pedersen O.;
J. Clin. Endocrinol. Metab. 90:219-224(2005)
Cited for: VARIANTS OBESITY TYR-36; THR-102; GLN-165; THR-175; ASP-181; VAL-219 AND PHE-325; VARIANTS ILE-103; MET-112 AND LEU-251; CHARACTERIZATION OF VARIANTS OBESITY TYR-36; THR-102; GLN-165; ASP-181; VAL-219 AND PHE-325;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.